Chinese traditional medicine and antibacterial drugs 274 standards open band procurement

TextsOn June 8, Fengqiu, Jinhua City, Zhejiang Province, the Medical Insurance Bureau issued "on the development of Jinhua City, the second batch of drug belt procurement announcement", has formed anti-infective primary research drugs, anti-infection non-original research drugs and traditional Chinese medicine and other three preliminary catalog, a total of 274 product regulations to carry out band procurementaccording to the batch procurement drug public catalog, Jinhua City, the second batch of shipments involved: 70 non-original antimicrobial drugs, including injection of alosilin sodium, amoxicillin kravicoacid capsules, injection of cephalosporine sodium, hydrochloric acid klinmycin injection, injection with meroponan, phosphate oseltamivir particles, etc.; Pirasillin sodium tamazine sodium, injection of amine perinan sodium, etc., 147 traditional Chinese medicine (excluding low-cost drugs) and 33 traditional Chinese medicine (including low-cost drugs), including compound fish fish herb, oxan yellow on-the-powder capsule, clear-cut-theure particles, dewind detox capsules, ginseng wheat injection, strong lychee, hundred-ring capsules, six-taste yellow pills, etcthe purchase volume, the relevant pharmaceutical institutions to estimate and report the next year's estimated procurement volume, in principle, anti-infective drugs according to the previous year's use of 60% statistics; The implementation cycle is tentatively scheduled for one yearquotations, anti-infective drugs according to the original research drug and non-original research drug quotation, to the current Zhejiang Province medical insurance payment standards (low-cost drugs to the linkage (procurement) price, the same below), the price reduction shall not be less than (including) 10%The maximum price of traditional Chinese medicine containing low-cost drugs in the same generic name regulations shall not be less than 10% less than (including) on the basis of the maximum price, and if the Chinese traditional medicine produced by an exclusive enterprise is a low-priced medicine, the price shall not be less than (inclusive) 20% on the basis of the maximum priceOther traditional Chinese medicines based on the current Standard of medical insurance payment in Zhejiang Province, the price reduction shall not be less than (including) 20%The review is divided by two links, the score and the expert vote high, such as the score of the same price low selectionin addition to the force majeure factors, the winning enterprise in the case of non-supply according to the agreement, can not guarantee the quality and supply of other circumstances, should bear the additional costs of drug replacement, otherwise it will be regarded as a breach of trust, the relevant breach of trust enterprise all products shall not be sold in the city procurement alliance all member units within two yearslist of specific drugs as follows: